Catherine Legrand

3.4k citations
48 papers · 2.7k · 1 hit paper · h-index 27

Impact in

    • Occupational and environmental lung diseases
    • Pleural and Pulmonary Diseases
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Medical Imaging and Pathology Studies
  • Oncology top 5%
    • Cutaneous Melanoma Detection and Management
    • Lung Cancer Research Studies

Papers in

Catherine Legrand

47 papers receiving 2.6k citations

Catherine Legrand's Hit Papers

Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada 2005 · 512 citations
5120+7+14Years since publication100200300400500

Peers

Catherine Legrand
Comparison fields: 5 of 123
  • Pulmonary and Respiratory Medicine 992
  • Oncology 624
  • Equine 35
  • Psychiatry and Mental health 246
  • Developmental Neuroscience 42
Replace Robert A. Montgomery with:
Robert A. Montgomery United States
Joe C. Rutledge United States
CLARE M. O'CONNOR Ireland
D. Kirk United Kingdom
Charles E. Barr United States
F. K. Mostofi United States
John T. Grayhack United States
Allen B. Cohen United States
William S. Fletcher United States
Takashi Tajiri Japan
Catherine Legrand relative to Robert A. Montgomery United States Robert A. Montgomery's profile →
Citations per field
00.5×5×11.6×
Robert A. Montgomery · 1×
Citations per year

Countries citing papers authored by Catherine Legrand

Since Specialization
Citations

This map shows the geographic impact of Catherine Legrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Legrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Legrand more than expected).

Fields of papers citing papers by Catherine Legrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Legrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Legrand. The network helps show where Catherine Legrand may publish in the future.

Co-authors

The 25 scholars most cited alongside Catherine Legrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Catherine Legrand Line = papers co-authored together Catherine Legrand links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada
Hit paper breakdown →
2005512
2 2010193
3 2005181
4 2006167
5 2013134
6 201193
7 199489
8 199887
9 201084
10 199678
11 201276
12 198973
13 201273
14 201072
15 201171
16 200764
17 201963
18 200660
19 199856
20 200350

About Catherine Legrand

Catherine Legrand is a scholar working on Statistics and Probability, Oncology, Pulmonary and Respiratory Medicine, Equine and Economics and Econometrics, having authored 48 papers that have together received 2.7k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (7 papers), Statistical Methods and Inference (7 papers), Statistical Methods in Clinical Trials (5 papers), Cutaneous Melanoma Detection and Management (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (992 citations), Oncology (624 citations), Equine (35 citations), Psychiatry and Mental health (246 citations) and Developmental Neuroscience (42 citations). Catherine Legrand has collaborated with scholars based in Belgium, France and Netherlands. Frequent co-authors include Jan P. van Meerbeeck, Giuseppe Giaccone, C. Debruyne, Rabab Mohamed Gaafar, Andrew J. Bottomley, Christian Manegold, Mark David Vincent, Per Carlsson, Eric A. Van Marck and Rob J. van Klaveren. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Aquatic Microbial Ecology, CHEST Journal and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact